When to Get Tested, When to Treat the Anxiety: A Practical Guide to Cognitive Symptoms in Later Life

You're at the pharmacy counter and the pharmacist is explaining how to take a new medication. You're nodding, but your mind is somewhere else, looping on that moment yesterday when you couldn't find the word you wanted. By the time you get to the car, you can't remember a thing the pharmacist said. Your chest tightens. Something is wrong with me.

But here's what's actually happening. Your brain runs on a limited supply of attention. Think of it like trying to read a book while someone talks loudly next to you. The book is still readable. Your eyes still work. But the noise steals your focus, and the words don't stick. Anxiety is that noise. When worry is running in the background, churning through the same fears over and over, it uses up the mental energy you need for everyday tasks like remembering names, following conversations, and keeping track of your keys.

And then something cruel happens. The forgetting makes you more anxious, which makes the forgetting worse. You start watching yourself for slips, grading every moment, and that watchfulness eats up even more of your attention. It's not your brain breaking down. It's your brain being asked to do two demanding jobs at once, and one of them, the worrying, won't stop. That's a different problem than the one you're afraid of. And it's one that has real solutions.

Not all forgetting works the same way. When anxiety is behind your memory lapses, the pattern looks specific. You forget your neighbor's name at a stressful family dinner, but it comes back to you easily the next morning. You blank on a word during a tense phone call, then use it perfectly an hour later. The forgetting comes and goes. It's tied to how you're feeling, not to a steady decline in what your brain can do.

There's another clue worth paying attention to. When anxiety is driving the trouble, you're usually the one keeping score. You notice every lapse, catalog it, compare today to yesterday. But the people closest to you, your spouse, your children, your friends, aren't alarmed. They haven't seen the pattern you're tracking. Research shows this matters. When genuine cognitive change is happening, it's often the people around you who spot it first, sometimes before you do yourself.

When forgetting doesn't follow your mood, when it's just as present on a calm, rested day as on a stressful one, when you can't recover the information even with hints, or when people who know you well start quietly noticing, those are different clues. They don't mean something terrible is happening. But they do mean a conversation with your doctor would be a brave and wise next step. Knowing which clues you're seeing puts you in a stronger position.

This is the part that changes things. When researchers helped older adults manage their anxiety through structured therapy, something else happened alongside the drop in worry: the memory complaints faded. People who spent months convinced their brains were failing found that as the anxiety lifted, so did the fog. They weren't sharper because they'd trained their memory. They were sharper because the thing hogging all their bandwidth finally quieted down.

There's a practical way to use this. If your forgetting is inconsistent, clearly worse when you're stressed, and you're also noticing more tension and worry than usual, a trial of anxiety treatment can be a first step. Eight to twelve weeks of talk therapy or working with your doctor on medication gives you real information. If the cognitive complaints ease as the anxiety does, that's a meaningful answer. If they don't, you haven't lost anything, and you have a clearer picture for the next conversation with your doctor.

Getting help for anxiety and getting a cognitive evaluation aren't an either-or choice. You can do both. Some people start with anxiety treatment and find that's all they needed. Others pursue both paths at once for peace of mind. The courage is in taking any step at all, choosing to understand what's happening rather than sitting alone with the fear. Not overnight. These improvements take weeks of sustained effort. But they're real, they happen at every age, and the fog does lift.

Your brain has a system called working memory. It's the mental workspace where you hold and manipulate information in real time: following directions, remembering what someone just said, doing mental arithmetic. Working memory has limited capacity. And anxiety, it turns out, is one of the most reliable things that shrinks it. When worry is running, it occupies part of that workspace. Rumination loops through the same fears, consuming the very resources you need for paying attention and encoding new information.

What researchers have found is that anxiety doesn't necessarily make you get the wrong answer. It makes getting the right answer cost more. You can still follow a recipe or balance your checkbook, but it takes significantly more mental effort than it used to. On a good day, you manage. On a bad day, when anxiety is high and the task is demanding, you hit a wall. That wall feels like cognitive decline. But it's cognitive overload. Your processing system is intact. It's just being asked to run two programs at once.

The vicious cycle is real and measurable. You forget something. The forgetting triggers fear: is this the beginning of something? The fear generates more anxiety. The anxiety takes up more working memory. You forget something else. Each lap through this cycle deepens the conviction that your brain is failing, even when the underlying cause is emotional, not neurological. Understanding this cycle is the first step toward breaking it.

Memory works in stages. First, information has to get in (encoding). Then it has to be stored. Then it has to be retrievable when you need it. Anxiety primarily disrupts the first stage. When you're worried, new information doesn't get properly encoded because your attention was elsewhere. The information never made it in, so it can't come back later. That's why you forget the pharmacist's instructions or your neighbor's new last name. It's not that the memory was stored and lost. It was never fully captured.

This is different from what happens in early neurodegeneration, where information gets encoded but then fades or can't be retrieved reliably. That pattern is more consistent. It doesn't depend on whether you're having a tense day or a calm one. Researchers have found that when people report cognitive decline, their self-assessment is often more closely tied to their mood than to their actual performance on cognitive tests. People with high anxiety consistently rate their memory as worse than it objectively is.

There's one more layer. The experience of being tested can itself make things worse. When people sit down for a cognitive assessment already worried about the outcome, that test anxiety consumes bandwidth and depresses their scores. Researchers call this "diagnosis threat." The fear of getting a bad result becomes a self-fulfilling prophecy in the testing room. Knowing this doesn't mean testing is useless. It means that a single anxious test session doesn't tell the whole story, and a good clinician accounts for your emotional state.

When older adults received cognitive behavioral therapy for their worry, researchers tracked not just their anxiety levels but their cognitive complaints. As anxiety dropped, the fog lifted. People reported better concentration, less forgetting, and more confidence in their thinking. This wasn't coincidence. The therapy freed up working memory that anxiety had been consuming. With more cognitive bandwidth available, everyday tasks became easier again.

Even beliefs about aging play a measurable role. In one line of research, older adults were told before a memory test that memory tends to decline with age. Another group heard that memory can remain strong. The group that heard the negative message performed worse, not because of any brain difference, but because the belief triggered anxiety that consumed cognitive resources. When researchers reduced that anxiety, performance improved. The implication: some of what looks like age-related decline is actually anxiety-related decline triggered by the expectation of decline.

A practical framework helps. If your memory concerns are inconsistent, clearly worse when you're worried, and accompanied by more overall tension, consider starting with anxiety treatment. Give it eight to twelve weeks. If the cognitive complaints ease alongside the anxiety, you've learned something important about what was driving them. If they persist, that's valuable information too, and a signal to pursue cognitive evaluation. Both paths are open to you at any point. The brave step is the first one.

Attentional Control Theory (Eysenck, Derakshan, Santos, & Calvo, 2007) makes a critical distinction: anxiety impairs processing efficiency (the resources required to perform a task) more than processing effectiveness (whether you ultimately get the correct answer). In practice, this means anxious older adults can still do most cognitive tasks, but they require significantly more effort and are more vulnerable to failure under high cognitive load. The theory identifies two specific executive functions most affected: the inhibition function (filtering out irrelevant stimuli) and the shifting function (flexibly switching between tasks). Both are essential for everyday memory encoding.

Beaudreau and O'Hara (2008) examined this relationship specifically in late life and found that anxiety was associated with attention and executive function deficits even after statistically controlling for depression. This is methodologically important because late-life anxiety and depression frequently co-occur, and earlier research often conflated their cognitive effects. Isolating anxiety's independent contribution clarified that the cognitive complaints older adults attribute to "getting old" may in many cases be attributable to untreated anxiety, a condition with well-established interventions.

Moran's 2016 meta-analysis of 177 studies quantified the relationship: anxiety was associated with moderate impairments in working memory updating and inhibition, with effect sizes in the range of d = 0.40 to 0.55. Vytal and colleagues demonstrated the load-dependent nature of this impairment using a dual-task design. Under low cognitive load, anxious participants performed comparably to controls. Under high load, their performance dropped significantly. The clinical implication is clear: your experience of "losing it" under pressure while being fine in quiet moments is precisely what the research predicts when anxiety, not neurodegeneration, is the driver.

The Subjective Cognitive Decline Initiative (Jessen et al., 2014) established a research framework for evaluating memory complaints in the absence of objective impairment. Their key insight: subjective complaints alone are a poor predictor of neurodegenerative disease. The SCD-I framework identifies features that increase predictive value: decline confirmed by an informant, objective decline over time on serial testing, onset within the last five years, age over 60, consistent worry about the decline, and a sense of performing worse than age-matched peers. When complaints exist without these features, the most common explanations are anxiety, depression, sleep disruption, and medication effects.

Hill and colleagues' 2016 systematic review of 47 studies found that affective symptoms, particularly anxiety and depression, were consistently and significantly associated with subjective cognitive complaints. The relationship between mood and self-reported cognitive decline was often stronger than the relationship between objective cognitive test performance and self-reported decline. Balash et al. (2013) reported a striking finding from a memory clinic: patients presenting with subjective memory complaints and comorbid anxiety had intact objective cognitive scores, while patients presenting with complaints but without anxiety were more likely to show measurable impairment. The presence of anxiety was, counterintuitively, a reassuring prognostic indicator.

Suhr and Gunstad's work on "diagnosis threat" (2002, 2005) demonstrated experimentally that priming cognitive concerns depresses test performance. Participants who were told that a test was evaluating cognitive decline performed worse than controls taking the identical test framed neutrally. This wasn't a demand characteristic or effort problem. It was genuine performance impairment from test anxiety consuming cognitive resources in real time. For older adults already worried about their memory, walking into a neuropsychological assessment carries inherent diagnosis threat. A sophisticated evaluator considers this context, but many standard cognitive screens don't account for the affective state of the person being tested.

Wetherell et al. (2013) tested a modular CBT approach for older adults with generalized anxiety in primary care settings. The intervention reduced anxiety significantly, and crucially, participants also reported improvements in subjective cognitive functioning and daily activity performance. This dual outcome supports the mechanism: as anxiety decreases, working memory resources become available for everyday cognitive demands. Mohlman and Gorman (2005) took this further by combining standard CBT with executive function training for anxious older adults. Both anxiety and objective cognitive performance improved, and the gains held at follow-up. The cognitive improvements weren't simply a mood-congruent reporting bias; they reflected genuine changes in measured performance.

The stereotype threat literature adds a sociocultural layer. Hess, Auman, Colcombe, and Rahhal (2003) showed that exposing older adults to negative aging stereotypes before a memory test significantly depressed their performance relative to controls. Haslam et al. (2012) found that interventions countering these stereotypes improved performance. The mediating pathway was partly anxiety: negative expectations triggered worry, which consumed working memory, which lowered scores. Reducing the anxiety component of stereotype threat restored cognitive performance. The implication extends beyond the laboratory: the cultural narrative that aging inevitably means cognitive decline may itself be contributing to cognitive complaints by maintaining chronic low-level threat appraisal.

A structured clinical approach follows from this evidence. When cognitive complaints present alongside elevated anxiety, inconsistent forgetting patterns, and absence of informant-confirmed decline, a therapeutic trial targeting anxiety is a defensible first step. Standard CBT protocols for late-life generalized anxiety typically show effects within eight to twelve weeks. If cognitive complaints resolve alongside anxiety reduction, the clinical picture is clear. If anxiety resolves but cognitive complaints persist, that discordance itself becomes clinically informative and supports proceeding to formal neuropsychological evaluation. Both pathways can run in parallel when clinical judgment warrants it. The point isn't to delay needed evaluation but to ensure the most common reversible cause is addressed rather than overlooked.

Attentional Control Theory (Eysenck, Derakshan, Santos, & Calvo, 2007) provides the mechanistic framework. Anxiety selectively impairs two components of Baddeley's working memory model: the central executive's inhibition function (suppressing task-irrelevant stimuli) and its shifting function (flexibly reallocating attention). The theory predicts that processing efficiency degrades before processing effectiveness, meaning anxious individuals can maintain accuracy but at substantially greater cognitive cost. Under high cognitive load, this compensatory strategy fails and performance declines. Eysenck and Derakshan (2011) refined the model to specify that anxiety increases stimulus-driven (bottom-up) attentional processing at the expense of goal-directed (top-down) control.

Moran (2016) quantified these effects across 177 studies in a comprehensive meta-analysis published in Psychological Bulletin. Anxiety was associated with impaired working memory updating (d = 0.55) and inhibition (d = 0.40), with the relationship holding across clinical and subclinical anxiety populations. Vytal, Cornwell, Arkin, and Grillon (2012) used a translational neuroscience approach: participants performed working memory tasks under conditions of unpredictable shock threat. Under low cognitive load, anxious performance was preserved. Under high load (three-back tasks), threat significantly impaired accuracy. The dissociation was clean and replicated, establishing that anxiety's cognitive toll is load-dependent.

Beaudreau and O'Hara (2008) brought this framework to late-life populations specifically. In their review, late-life anxiety was independently associated with attentional and executive function deficits after controlling for depressive symptomatology, a methodological control that earlier studies frequently omitted. The practical significance: older adults presenting with attention complaints, executive dysfunction, and subjective memory decline may be manifesting anxiety-mediated cognitive impairment rather than preclinical neurodegenerative disease. The pathway is reversible when the anxiety is addressed, making accurate differential assessment a clinical priority with direct treatment implications.

The Subjective Cognitive Decline Initiative (Jessen et al., 2014, Alzheimer's & Dementia) proposed a standardized research framework addressing the low specificity of subjective cognitive complaints for preclinical Alzheimer's disease. SCD alone had sensitivity but poor specificity; the SCD-plus criteria improved predictive value by requiring features including informant-confirmed decline, measurable longitudinal worsening, onset within five years, age over 60, associated worry, and subjective performance below age-matched norms. Without these additional features, subjective complaints were more commonly attributable to affective disorders, sleep pathology, medication effects, or normal aging awareness.

Hill et al. (2016) conducted a systematic review of 47 studies examining the relationship between subjective cognitive impairment and affective symptoms, published in The Gerontologist. Across studies, anxiety and depressive symptoms were consistently and significantly associated with subjective cognitive complaints. The association between affective state and self-reported decline was frequently stronger than the association between objective neuropsychological performance and self-reported decline. Balash et al. (2013) reported clinical data from a memory clinic sample: patients presenting with subjective memory complaints and comorbid anxiety demonstrated intact performance on objective cognitive testing, while patients with complaints in the absence of anxiety were significantly more likely to show objective impairment. Anxiety served as a paradoxical protective indicator in the differential.

Suhr and Gunstad (2002, 2005) experimentally demonstrated "diagnosis threat," showing that expectation of cognitive decline produces genuine performance decrements on neuropsychological measures. Their experimental design controlled for malingering and effort: participants were engaged and trying. The impairment resulted from anxiety consuming cognitive resources during testing. For older adults presenting with memory concerns, the assessment context itself carries inherent threat, creating a confound that standard cognitive screens rarely address. Comprehensive neuropsychological evaluation should account for state anxiety, and serial testing across sessions with varying anxiety levels provides more reliable data than a single high-stakes assessment session.

Wetherell et al. (2013, American Journal of Geriatric Psychiatry) evaluated modular CBT for late-life generalized anxiety in primary care, finding significant reductions in anxiety severity alongside improvements in subjective cognitive functioning and daily activity performance. The parallel trajectory of improvement supports the mechanistic model: as anxiety decreases, working memory resources previously consumed by worry become available for cognitive operations. Mohlman and Gorman (2005, Behaviour Research and Therapy) tested CBT augmented with executive function training in older adults with GAD. Both anxiety and measured executive function improved, with gains maintained at follow-up. The augmented approach was theoretically motivated by Attentional Control Theory's prediction that strengthening executive control would address both the anxiety and its cognitive consequences.

Pharmacological evidence converges with the psychotherapy data. Lenze et al. (2014) found that escitalopram treatment for late-life GAD was associated with improvements in processing speed and executive function, supporting the hypothesis that anxiety reduction through any effective mechanism frees cognitive resources. The stereotype threat literature provides additional mechanistic evidence: Hess et al. (2003, Journal of Gerontology) demonstrated that negative aging stereotypes impaired older adults' memory performance, with the effect partially mediated by state anxiety. Haslam et al. (2012) showed that countering negative stereotypes improved performance, and the improvement pathway ran partly through anxiety reduction. The convergence across CBT, pharmacotherapy, and stereotype threat reduction strengthens the causal inference that anxiety is a modifiable contributor to late-life cognitive complaints.

The clinical decision framework that emerges: when cognitive complaints co-occur with elevated anxiety, show inconsistent or context-dependent patterns, and lack informant corroboration or objective longitudinal decline, a structured anxiety treatment trial of eight to twelve weeks constitutes both a therapeutic intervention and a diagnostic probe. Resolution of cognitive complaints with anxiety reduction provides strong evidence for anxiety-mediated etiology. Persistence of cognitive complaints despite successful anxiety treatment argues for formal neuropsychological evaluation with appropriate correction for residual affective state. The two approaches aren't sequential in all cases; concurrent pursuit is appropriate when clinical features are ambiguous. The overarching principle: reversible causes should be addressed before irreversible diagnoses are assumed, and anxiety is the most prevalent reversible contributor to cognitive complaints in later life.